Incannex Healthcare (IXHL) Expected to Announce Earnings on Monday

Incannex Healthcare (NASDAQ:IXHL) is anticipated to issue its Q4 2025 results before the market opens on Monday, September 29th. Analysts expect the company to announce earnings of ($0.29) per share for the quarter. Parties may review the information on the company’s upcoming Q4 2025 earningreport for the latest details on the call scheduled for Friday, October 3, 2025 at 9:30 AM ET.

Incannex Healthcare Stock Down 0.0%

NASDAQ:IXHL opened at $0.59 on Friday. The business’s 50 day moving average is $0.61 and its two-hundred day moving average is $0.47. Incannex Healthcare has a 52 week low of $0.08 and a 52 week high of $3.12. The company has a market cap of $17.51 million, a PE ratio of -0.49 and a beta of 7.66.

Analyst Ratings Changes

Separately, Wall Street Zen raised Incannex Healthcare to a “hold” rating in a research note on Friday, July 18th.

Incannex Healthcare Company Profile

Incannex Healthcare Inc, a clinical stage pharmaceutical development company, engages in the research, development, and sale of medicinal cannabinoid and psychedelic pharmaceutical products and therapies. It develops products for the treatment of obstructive sleep apnoea (OSA), traumatic brain injury (TBI) and concussion, lung inflammation (ARDS, COPD, asthma, bronchitis), rheumatoid arthritis, inflammatory bowel disease, anxiety disorders, addiction disorders, pain, and other indications.